TipRanks on MSN
Pfizer’s New Study on Ibrance: What Investors Need to Know
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. has announced a new clinical study titled ‘Real-world ...
Oct 9 (Reuters) - Pfizer Inc (PFE.N), opens new tab said on Friday its cancer drug Ibrance did not meet the main goal in a late-stage trial in patients with a type of breast cancer, the latest setback ...
WSAV Savannah on MSN
Breast cancer survivor talks battling disease for third time
Kelsea Ballerini gave a shout-out to her antidepressant medication in her latest life update. The “Cowboys Cry Too” singer, ...
We’re still waiting on lawmakers to reach a deal to reopen the government, but the coming weeks could yield news on the ...
Zacks.com on MSN
Pfizer's Q3 Non-Oncology Performance: Here's What to Expect
Pfizer's Q3 results are set to reveal mixed trends across non-oncology drugs, with strong Eliquis and Paxlovid sales offset ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback